Qof stroke indicators
WebGoals and outcome measures QOF indicators Chronic kidney disease: QOF indicators Last revised in February 2024 Print this page Summary Table 1. Indicators related to chronic kidney disease (CKD) in the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract. Back to top WebThe Cardiovascular Series: IIF and QoF Indicators in CVD webinar is prioritised, and FREE, for Primary Care, PCN, ICB and GP Practice Pharmacists, Pharmacy Technicians and Trainees. ... AF – Indicators 006 & 007. Assessing stroke risk and implementing anticoagulation on a population basis; CHD – Indicator CHD 005. 008 & 009 Antiplatelets ...
Qof stroke indicators
Did you know?
WebThis NICE menu of QOF indicators is a full list of indicators that have been developed by NICE. NHS England and the UK devolved administrations will use the NICE QOF menu to help decide which indicators are included in the QOF within their countries. Filter by indicator area: Mental health WebApr 20, 2024 · Indicator 1: The contractor establishes and maintains a register of patients with stroke or TIA (STIA001) Indicator 2: The percentage of patients aged 79 years or …
WebThe QOF indicators for Chronic Kidney Disease (CKD) are based on a practice register of people aged over 18 with chronic kidney disease from any cause. Inclusion in the register is based on estimated Glomerular Filtration Rate (eGFR), a measure of kidney function. ... Stroke and Transient Ischaemic Attack (TIA) WebSep 10, 2024 · The four flu indicators for patients with coronary heart disease, COPD, stroke/TIA and diabetes – the number of points attached to these is doubled. The two …
WebQOF: Exception reporting. There is no doubt that the quality and outcomes framework (QOF) is going to be a greater challenge to practices this year than it ever has been. Increases to thresholds and the introduction of a … WebNov 30, 2024 · The National Institute for Health and Care Excellence (NICE) has published two draft indicators1—for atrial fibrillation and for people with severe mental illness—that could be included in the 2024-24 Quality and Outcomes Framework (QOF).. The first potential indicator, anticoagulants for people with atrial fibrillation and an increased risk …
WebSTIA003. The percentage of patients with a history of stroke or TIA in whom the last blood pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less 5 …
WebDiabetes - type 1: QOF indicators Last revised in January 2024 Summary Have I got the right topic? How up-to-date is this topic? Goals and outcome measures Goals Outcome measures Audit criteria QOF indicators QIPP - Options for local implementation NICE quality standards Background information Diagnosis Management Supporting evidence duan corporation mndual zone wine coolers+optionsWebGeneral practice indicator suitable for use in the QOF. October 2024. NM180. The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia who have been screened for hazardous drinking using the FAST or AUDIT-C tool in the preceding 2 years. dual zone wine fridge 24Web8 rows · Indicators related to stroke and transient ischaemic attack (TIA) in the Quality … commonly used in batteries elementWebFeb 1, 2024 · Hypertension will also see changes, with the HYP003 indicator will be reintroduced that sees patients under 79 controlled to 140/90mmHg, and targets extended to patients with coronary heart disease and stroke/TIA. commonly used inhalantsWebMar 22, 2024 · A change to a negative trend occurred in five of the 16 indicators over the three year period (mental health care planning, and blood pressure ≤150/90 mm Hg in people with peripheral arterial disease, stroke or transient ischaemic attack, coronary heart … commonly used inductor valuesWebNov 30, 2024 · The other, covering anticoagulants for people with atrial fibrillation and an increased risk of stroke, is an update to an existing QOF indicator. It ‘differentiates between direct-acting oral anticoagulants (DOACs) and vitamin K antagonists’ and ‘aims to promote the use of DOACs over vitamin K antagonists, unless DOACs are declined by ... commonly used ingredients